(Total Views: 627)
Posted On: 09/13/2021 4:49:18 PM
Post# of 148870
"No drug-related serious adverse events or dose-limiting toxicity was reported."
after IV infusion with Pro 140 (leronlimab)
From the 2008 study.
https://academic.oup.com/jid/article/198/9/1345/834086
after IV infusion with Pro 140 (leronlimab)
From the 2008 study.
https://academic.oup.com/jid/article/198/9/1345/834086
(4)
(0)
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.
Scroll down for more posts ▼
